Zhejiang Zhenyuan Share Co.,Ltd. Stock: price and insider trades · China
浙江震元
No insider purchase over the last 90 days. The latest, by 吴海明, was filed 20 May 2022.
Zhejiang Zhenyuan Share Co.,Ltd.: what insiders have been doing
Zhejiang Zhenyuan Share Co.,Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SSE / SZSE (CSRC). Zhejiang Zhenyuan Share Co.,Ltd. has had no insider filing for more than a year; the last one goes back to 20 May 2022.
Since 2022, the database holds 3 purchases and no sales by insiders of the company.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Since the insiders bought
- +3.1%Entry CN¥8.14 · Close at T+365 CN¥8.39
- +5.7%Entry CN¥7.94 · Close at T+365 CN¥8.39
- +5.7%Entry CN¥7.94 · Close at T+365 CN¥8.39
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 10,000 shares100.0% of flowA股XSHESZSE:173000005542938530Canonical exit: 18 Aug 2022 (T+90)
- 20,000 shares100.0% of flowA股XSHESZSE:173000005539586080Canonical exit: 17 Aug 2022 (T+90)
- 15,000 shares100.0% of flowA股XSHESZSE:173000005539680740Canonical exit: 17 Aug 2022 (T+90)
3 of 3 declarations
About Zhejiang Zhenyuan Share Co.,Ltd.
Zhejiang Zhenyuan is a company specializing in the health and pharmaceutical sector. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
